Skip to content
★ Sign in to follow
PB

Premier Biomedical Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by FELDER MITCHELL S, was filed 27 Mar 2020.

Premier Biomedical Inc: what insiders have been doing

Premier Biomedical Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Premier Biomedical Inc has published a filing in the past twelve months. The most recent one dates from 27 March 2020.

The full history, which starts in 2012, counts 29 purchases against 18 sales.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
66
Thresholds
n/a
Buy Volume
€145,385
29 ops. · all time
Sell Volume
€131,253
18 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2019

FY ended December 2019 · cache

Income statement
Revenue12.7k
Gross profit1.3k10% margin
Net income-333.8k-2622.2% margin
Last declaration on 27 March 2020
Declarations66 total
  • ▲
    Chairman of the BoardExecutives
    4,500 USD16SEC
    3,000,000 shares@ US$0.001526.3% of flowCommon StockSEC:0001654954-20-003395:0
    Canonical exit: 24 Jun 2020 (T+90)
  • ▲
    Chairman of the BoardExecutives
    2,600 USD14SEC
    2,000,000 shares@ US$0.001315.0% of flowCommon StockSEC:0001654954-20-003395:1
    Canonical exit: 25 Jun 2020 (T+90)
  • ▲
    Vice PresidentExecutives
    1,500 USD31SEC
    5,000,000 shares@ US$0.0003100.0% of flowCommon StockSEC:0001654954-20-001119:0
    Canonical exit: 4 May 2020 (T+90)
  • ▲
    Chairman of the BoardExecutives
    3,000 USD14SEC
    10,000,000 shares@ US$0.00038.5% of flowCommon stockSEC:0001654954-20-001103:0
    Canonical exit: 3 May 2020 (T+90)
  • ▲
    Chairman of the BoardExecutives
    100 USD13SEC
    10,000 shares@ US$0.010.3% of flowcommon stockSEC:0001654954-19-010785:0
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    2,187 USD14SEC
    220,955 shares@ US$0.00996.3% of flowcommon stockSEC:0001654954-19-010785:2
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    1 USD13SEC
    100 shares@ US$0.010.0% of flowcommon stockSEC:0001654954-19-010785:3
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    1,900 USD14SEC
    190,000 shares@ US$0.015.4% of flowcommon stockSEC:0001654954-19-010785:4
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    1,688 USD13SEC
    168,845 shares@ US$0.014.8% of flowcommon stockSEC:0001654954-19-010785:5
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    142 USD13SEC
    17,700 shares@ US$0.0080.4% of flowcommon stockSEC:0001654954-19-010785:7
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    800 USD13SEC
    100,000 shares@ US$0.0082.3% of flowcommon stockSEC:0001654954-19-010785:8
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    318 USD13SEC
    39,800 shares@ US$0.0080.9% of flowcommon stockSEC:0001654954-19-010785:9
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    177 USD13SEC
    22,100 shares@ US$0.0080.5% of flowcommon stockSEC:0001654954-19-010785:10
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    1,807 USD14SEC
    220,400 shares@ US$0.00825.2% of flowcommon stockSEC:0001654954-19-010785:11
    Canonical exit: 15 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    2,400 USD12SEC
    300,000 shares@ US$0.0086.9% of flowCommon StockSEC:0001654954-19-010598:0
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    820 USD11SEC
    100,000 shares@ US$0.00822.3% of flowCommon StockSEC:0001654954-19-010598:1
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    2,050 USD12SEC
    250,000 shares@ US$0.00825.9% of flowCommon StockSEC:0001654954-19-010598:2
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    248 USD11SEC
    30,250 shares@ US$0.00820.7% of flowCommon StockSEC:0001654954-19-010598:3
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    10 USD11SEC
    1,207 shares@ US$0.00850.0% of flowCommon StockSEC:0001654954-19-010598:4
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    900 USD11SEC
    100,000 shares@ US$0.0092.6% of flowCommon StockSEC:0001654954-19-010598:5
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    1,490 USD11SEC
    156,892 shares@ US$0.00954.3% of flowCommon StockSEC:0001654954-19-010598:6
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    380 USD11SEC
    40,000 shares@ US$0.00951.1% of flowCommon StockSEC:0001654954-19-010598:7
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    267 USD11SEC
    28,108 shares@ US$0.00950.8% of flowCommon StockSEC:0001654954-19-010598:8
    Canonical exit: 10 Dec 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    5,419 USD9SEC
    742,356 shares@ US$0.007315.2% of flowCommon StockSEC:0001654954-19-009055:0
    Canonical exit: 5 Nov 2019 (T+90)
  • ▲
    Chairman of the BoardExecutives
    1,881 USD8SEC
    257,644 shares@ US$0.00735.3% of flowCommon StockSEC:0001654954-19-009055:1
    Canonical exit: 5 Nov 2019 (T+90)

25 of 66 declarations

About Premier Biomedical Inc

Premier Biomedical Inc is a company focused on developing innovative biomedical solutions. It is listed on NASDAQ under the ticker XNAS.